MyLymphomaTeam

DLBCL is considered a high-grade but potentially curable form of lymphoma. While doctors typically use the term "complete response" or "complete remission" rather than "cancer-free," achieving long-term remission with no detectable cancer cells is possible.

The outlook is encouraging - about 75% of people achieve complete Show Full Answer

DLBCL is considered a high-grade but potentially curable form of lymphoma. While doctors typically use the term "complete response" or "complete remission" rather than "cancer-free," achieving long-term remission with no detectable cancer cells is possible.

The outlook is encouraging - about 75% of people achieve complete response after initial R-CHOP treatment. Of those who achieve complete response, more than 80% will remain cancer-free at the 5-year mark. The longer someone stays in remission, the lower their chance of relapse becomes. Research shows very low rates of late relapses:
• Only 6.9% relapse after 3 years
• 9.3% relapse after 5 years
• 10.3% relapse after 8 years

Early diagnosis and treatment significantly improve outcomes - for example, stage 1 DLBCL has a 79.2% five-year survival rate. While doctors may be hesitant to use the term "cured," many people do achieve and maintain long-term cancer-free status.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

DLBCL Relapse Rate and Treatment Options

Remission and Complete Response in DLBCL: How Long It Lasts and More